4-Aminobenzonitrile is a versatile aromatic compound with various applications. It is a key intermediate in the synthesis of many pharmaceutical and agrochemical products. Its synthesis typically involves the reaction of 4-nitrobenzonitrile with a reducing agent such as iron powder or hydrogen gas. 4-Aminobenzonitrile exhibits biological activity as a potential anticancer agent. Its ability to inhibit the growth of cancer cells is attributed to its interaction with DNA and its potential to interfere with cell cycle progression. Due to its diverse applications and biological activity, 4-aminobenzonitrile is extensively studied in the fields of organic synthesis, medicinal chemistry, and material science.'
| ID Source | ID |
|---|---|
| PubMed CID | 13396 |
| SCHEMBL ID | 55548 |
| MeSH ID | M0131744 |
| Synonym |
|---|
| einecs 212-850-1 |
| nsc 7625 |
| brn 0774507 |
| ai3-24185 |
| 4-cyanoaniline |
| 873-74-5 |
| nsc7625 |
| p-aminobenzonitrile |
| benzonitrile, 4-amino- |
| aniline, p-cyano- |
| 1-amino-4-cyanobenzene |
| p-cyanoaniline |
| benzonitrile, p-amino- |
| wln: zr dcn |
| nsc-7625 |
| 4-aminobenzonitrile , |
| AC-907/34118024 |
| inchi=1/c7h6n2/c8-5-6-1-3-7(9)4-2-6/h1-4h,9h |
| benzoic acid,4-amino,nitrile |
| 4-aminobenzonitrile, 98% |
| STK080905 |
| A0695 |
| AKOS000119675 |
| 4-azanylbenzenecarbonitrile |
| A842114 |
| 4-amino-benzonitrile |
| pb8v69y76t , |
| unii-pb8v69y76t |
| 4-14-00-01158 (beilstein handbook reference) |
| akos b029065 |
| 4-aminophenylnitrile |
| 4-cyanobenzenamine |
| 4-cyanobenzeneamine |
| 4-aminobenzenenitrile |
| p-cyanophenylamine |
| 4-cyanophenylamine |
| FT-0601337 |
| AM20060059 |
| cyanoaniline, p- |
| BP-21363 |
| SCHEMBL55548 |
| PS-6161 |
| 4-aminobezonitrile |
| 4-cyano aniline |
| 4-cyanoanilin |
| 4-cyano-phenylamine |
| p-cyanoaniiine |
| 4-cyanophenyl amine |
| p-amino benzonitrile |
| 4-amino benzonitrile |
| DTXSID0061240 |
| W-104029 |
| F5608-0079 |
| mfcd00007821 |
| CS-D1531 |
| S12319 |
| Z57073771 |
| BCP04531 |
| Q27286445 |
| 4-diazo-n,n-diethylanilinefluoroborate |
| EN300-17909 |
| 4-aminobenzonitrile-2356-d4 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (39.76) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 14 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||